Article

marketwatch.com on 2020-08-14 12:46

CureVac raises $213.3 million in IPO after pricing at $16 a share, high end of proposed range

CureVac BV, a clinical-stage biotech headquartered in Germany, priced its initial public offering on Friday at $16 a share, the high end of its proposed...

Related news